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EOSINOPHIL ATTRACTING SUBSTANCES (EOSINOTAXINS) EXTRACTED
FROM HUMAN EPIDERMIS*
RICHARD B. STOUGHTON, M.D.t
This report concerns the presence in human
epidermis of a substance capable of attracting
eosinophils out of the blood vessels of the corium
into the surrounding connective tissue. This
factor will be referred to as eosinotaxin. It was
originally observed by the author that large
numbers of eosinophils accumulated around the
blood vessels of the corium one to two hours
following mild thermal injury (1). The eosino-
phi1 seemed to accumulate beneath epidermal
cells which were undergoing acantholysis. This
led to the speculation that breakdown products
of the epidermis were acting as eosinotaxins.
This is a report of the above speculation sub-
jected to experiment.
METRODS
Human volunteers were used. Biopsy specimens
of normal skin were taken from the back or fore-
arm. The epidermis was removed by heating the
skin to 55°C. for one minute (this represents the
thermal damage referred to hereinafter) or slicing
the epidermis off with a razor or stretching it off,
depending on the experiment to be done. The
epidermis was then treated in different ways. a)
After thermal damage, it was immediately ground
in a glass homogenizer, centrifuged and the super-
nate recovered. b) After thermal damage it was
incubated at 37°C. for four hours and then ground
in a glass homogenizer, centrifuged and the super-
nate recovered. c) Sliced fresh epidermis was
incubated at 37°C. without any previous thermal
damage, ground in a glass homogenizer, centri-
fuged and the supernate recovered. d) Sliced fresh
epidermis was ground in a glass homogenizer,
centrifuged and the supernate recovered. e)
Frozen epidermis was separated by the stretch
method (2), incubated at 37°C. with trypsin (1
mgm/cc) for two hours, ground in a glass homoge-
nizer, centrifuged and the supernate recovered.
f) Frozen epidermis was separated by the stretch
method, ground in a glass homogenizer, centri-
fuged and the supernate recovered. Trypsin (1
mgm/cc) was added to the supernate before injec-
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tion into skin. g) Sliced fresh epidermis was incu-
bated at 37°C. with trypsin (1 mgm/cc) for two
hours, ground in a glass homogenizer, centrifuged
and the supernate recovered.
To all the above preparations were added phys-
iological saline or 0.1 M phosphate buffer pH 7.0.
Usually one specimen in each category was pre-
pared in saline and one in the phosphate buffer.
As there were no remarkable differences between
the results obtained with the saline and phosphate
buffer the results are reported as the average ob-
served with the two different preparations.
Controls were set up as follows:
h) Trypsin (1 mgm/cc) + 0.1 M phosphate buf-
fer pH 7.0 + incubation for two hours at 37°
C.
i) Trypsin (1 mgm/cc) + saline
j) Trypsin (1 mgm/cc) + 0.1 M phosphate
buffer pH 7.0
k) Physiological saline
1) Needle puncture only.
A final series of experiments were designed to
examine the inflammatory response in human skin
resulting from injection of trypsin digests of
casein and albumin and a few amino acids. 5%
casein and 5% albumin in 0i M phosphate buffer
pH 7.0 were digested with trypsin (1 mgm/cc) for
two hours at 37° C. These preparations were
passed through a millipore ifiter before injection
into skin. Histidine, cysteine, leucine and arginine
(0.01 M in distilled water) were also injected.
The extracts of epidermis, after passage through
millipore filters, were injected into the skin of
the individual from whom the sample of epidermis
was obtained. The injection site was the forearm.
Two hours after injection a 4—5 mm. biopsy speci-
men was taken from the injection site. The same
procedure was followed for the controls. Each
result therefore represents a different subject.
Peripheral eosinophil counts were made from
blood smears. The blood was obtained by finger
prick. All subjects had a peripheral eosinophil
count of less than 2%.
The biopsy specimens were fixed in formalin
and processed in the usual way for hematoxylin
and eosin staining. Total inflammatory cells were
counted in two 6 sections from each subject and
the eosinophils are expressed as per cent of total
cell count. Results are expressed as average count
per section for both phosphate buffer and saline
preparations.











a) Thermal damage oniy 128 3 2.3
b) Thermal damage + incu- 140 26 18.6
bation
e) Sliced epidermis + incu- 180 4 2.2
bation
d) Sliced epidermis only 170 2 1.2
e) Frozen epidermis + tryp- 182 85 47.0
sin + incubation
1) Frozenepidermis-f-tryp- 142 3 2.1
sin (no incubation)
g) Sliced epidermis + tryp- 260 45 17.0
sin + incubation
h) Trypsin + P04 buffer + 24 0 0
incubation
i) Trypsin + saline 12 0 0
j) Trypsin + P04 buffer 15 0 0
k) Saline 3 0 0
1) Needle puncture only 5 0 0
m) Casein digest 250 6 2.7
n) Albumin digest 352 5 1.9
o) Histidine 45 0 0
p) Cysteine 165 1 0.6
q) Arginine 172 0 0
r) Leucine 225 1 0.4
* Alphabetical listing is such that (a) in the
Table represents (a) in Methods so that details
of each procedure can be found under the same
letter listed in Methods.
RESULTS
The results of all the experiments are summa-
rized in Table I.
Epidermis exposed to thermal injury alone
apparently does not release any significant
eosinotaxic factor. However if thermally injured
skin is incubated at 37°C., an eosinotaxic factor
seems to be released. Also, trypsin is capable of
liberating an eosinotaxic factor from epidermis.
Frozen skin seemed to be a better source than
fresh skin for the eosinotaxic factor liberated by
trypsin. The controls with trypsin alone, the
diluents (P04 buffer and saline), needle puncture
only, casein and albumin digests and some amino
acids, did not act as eosinotaxins.
DISCUSSION
This preliminary study definitely indicates
that the epidermis is capable of liberating an
eosinotaxic factor under proper conditions. In
view of a previous report concerning enzymatic
acantholysis following thermal injury (3) asso-
ciated with an increase in eosi.nophils in the
infiltrate below and the present demonstration
of liberation of an eosinotaxin by trypsiri, one
might guess that the factor is a breakdown
product of the epidermal cell, possibly a poly-
peptide.
To my knowledge there is no work extant
indicating that there is a substance in human
skin which will act as an eosinotaxin. The work
of Menkin (4) definitely indicates that there
are rather specific sources for leukotaxin although
the exact chemical nature of leukotaxin, if it is
in fact a single compound, is unknown (5).
Cullembine has observed that dermal protease
will liberate leukotaxins from fibrin (6). It is
quite conceivable and probable that many dermal
infiltrates are the result of chemical "messages"
received from damaged epidermal cells.
There may be cause to challenge the term
eosinotaxin. The dynamic picture of migration
of cells out of blood vessels was not observed
but assumed. The possibility of conversion of
another cell type to the eosinophil after migra-
tion of the cell out of the blood vessel is a remote
possibility as is the conversion of a connective
tissue cell not of intravascular origin. However,
with the assumption that the extravascular
eosinophils observed have migrated from the
vessels, it seems reasonable to assume an eosino-
taxie factor.
The question of eosinophils, their origin and
attraction, is an important one in dermatology.
Most cases of exfoliative dermatitis are associated
with an elevated number of eosinophils in the
blood as are many cases of neurodermatitis,
Sulzberger-Garbe disease, pemphigus and derma-
titis herpetiformis. Many of the above skin
diseases and others are also associated with
increased tissue eosinophilia. A comprehensive
review of the problem of the relation of eosino-
phils to disease or basic pathological reactions is,
unfortunately, far beyond the limits of this short
report.
SUMMARY
1) Preliminary work indicates that breakdown
products of human epidermis are capable of
acting as eosinotaxins.
2) Liberation of eosinotaxin from epidermis
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may be effected by trypsin or thermal damage
plus subsequent incubation at 37° C.
3) A few amino acids and trypsin digsets of
casein and albumin were shown to be devoid of
eosinotaxic activity.
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